MEDPAL AI is trading 5.7% up at £3.38 as investors reassess the growth rationale behind a recent £5 million equity raise that had previously triggered a sharp sell-off.
- The stock is recovering from dilution concerns following the capital raise at a discounted 3.5p per share, with buyers returning as selling pressure subsides.
- The rebound is a stock-specific move occurring against a weaker healthcare sector backdrop, which has been dampened by profit outlook cuts at several major operators.